INTRODUCTION
Terpenoids are a large, varied and widespread group of natural compounds. The terpenoids synthesized by the fungus Gibberella fujikuroi include carotenoids, responsible for the orange pigmentation of the mycelium, and gibberellins, which act as hormones in plants (Rademacher, 1997) . Important physiological functions are carried out in cells by sterols, dolichols, ubiquinone, and farnesyl and geranylgeraniol groups added to many proteins (Chappell, 1995a, b) .
All natural terpenoids are derived from geranyl diphosphate (Mende et al., 1997) . The sterols, gibberellins and carotenoids of G. fujikuroi are synthesized through a pathway that includes 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) and -mevalonate (Coolbaugh, 1983 ; Domenech et al., 1996) . These intermediaries are not used in an alternative pathway as found in other organisms, which starts with glyceraldehyde 3-phosphate and pyruvate (Rohmer et al., 1993) .
Labelling experiments led to the conclusion that the pathways for different terpenoids, including their common sections, must occur in different cellular compartments. This is the case for carotene and sterol biosyntheses in Phycomyces blakesleeanus (Bejarano & Cerda! -Olmedo, 1992) , and carotenoid, sterol and gibberellin biosyntheses in G. fujikuroi (Domenech et al., 1996) . Terpenoid biosynthesis in different compartments was also shown in animals (Biardi & Krisans, 1996) and, as metabolic channels, in plants (Chappell, 1995b) .
HMG-CoA reductase (EC 1;1;1;34) catalyses the conversion of HMG-CoA to mevalonate. Genes for this enzyme have been isolated from several organisms. All of them contain a highly conserved, hydrophilic catalytic domain and a variable number of less conserved transmembrane domains (Hampton et al., 1996) . Whereas in animals there appears to be only one gene for HMG-CoA reductase, two or more genes have been found in Saccharomyces cerevisiae and in different plants (Basson et al., 1988 ; Chappell, 1995a from G. fujikuroi can be readily isolated using degenerate oligonucleotides with sequences that are highly conserved in all homologous genes (Corrochano & Avalos, 1992 ; Woitek et al., 1997) .
A powerful inhibitor of this enzyme is a compound now most frequently called lovastatin, previously known as monacolin K when isolated from Monascus ruber and mevinolin when isolated from Aspergillus terreus (Endo & Hasumi, 1997) . Lovastatin inhibits growth in many organisms, often at very low concentrations, presumably because of the inhibition of the synthesis of essential terpenoids (Florin-Christensen et al., 1990 ; Lam & Doolittle, 1992 ; Haag et al., 1994 ; Morehead et al., 1995) .
In this paper we show that while lovastatin did not significantly affect the growth and production of sterols and carotenoids in G. fujikuroi, it did inhibit its gibberellin production. Our results support the existence of independent compartments for the biosynthesis of various terpenoids in this fungus.
METHODS
Strains and culture conditions. This work was carried out utilizing the standard wild-type strain IMI 58289 of G. fujikuroi and its mutant strain SG22. Since the wild-type strain produces very few carotenoids, we utilized strain SG22. This strain is particularly suitable for the detection of effects on carotenoid biosynthesis since it accumulates mostly neurosporaxanthin at a constant high rate over a period of many days (Avalos & Cerda! -Olmedo, 1987) . Both strains were grown from spores in 125 ml Erlenmeyer flasks containing 25 ml low-nitrogen minimal liquid medium, and incubated at 30 mC in an orbital shaker (about 150 r.p.m.). The minimal medium (Geissman et al., 1966) contained 80 g -glucose l − " as carbon source and 0n48 g NH % NO $ l − " as the nitrogen source. Each flask was inoculated with approximately 10' spores collected from a culture grown in a Petri dish with sporulation agar (Avalos et al., 1985) . After growth, mycelium was collected by filtration, washed with water, and lyophilized, or dried for 3 h at 105 mC, before determination of dry weights. Under our experimental conditions, gibberellin biosynthesis started after 3 d vegetative growth, following the exhaustion of the nitrogen source (Candau et al., 1992) .
Biochemical analyses. Carotenoids were extracted with acetone and the dried extracts were redissolved in n-hexane for spectrophotometry. The total amounts of coloured carotenoids (Ferna! ndez-Martı! n et al., 1995) or ergosterol (Domenech et al., 1996) were estimated from absorbance determinations. The total gibberellin concentrations in culture media were estimated fluorometrically (Candau et al., 1991) after removal of mycelium by filtration.
To assay HMG-CoA reductase, washed mycelium was frozen in liquid nitrogen, ground in a mortar, and extracted by suspension in HEPES\sucrose\NaCl\EDTA\EGTA buffer, pH 7n4, plus protease inhibitors as described by Pen4 a-Dı! az et al. (1997) . The lysate was then cleared by centrifugation at 1000 g for 2 min. HMG-CoA reductase was assayed by utilizing 25-50 µg protein from the supernatant and -3-hydroxy-3-methyl-[3-"%C]glutaryl-CoA (Amersham International) as substrate as described by Shapiro et al. (1974) with the modification of Pen4 a-Dı! az et al. (1997) . Each sample contained 0n4 mM of the radioactive substrate (specific radioactivity : 2550 d.p.m. nmol − "), 25 mM EDTA, 1n6 mM DTT, 30 mM glucose 6-phosphate, 3 mM NADP, 50 milliunits glucose-6-phosphate dehydrogenase in a final volume of 75 µl. Under the assay conditions described the determinations were linear up to at least 30 min incubation. To study the effect of lovastatin in vitro, it was added, as the sodium salt, to cell-free extracts at concentrations indicated in the text or figures. The activity of HMG-CoA reductase was expressed as pmol HMGCoA converted to mevalonate min − " (mg protein) − ". Protein was determined as described by Bradford (1976) , using BSA as standard. The analytical results are the mean and its standard error from three independent experiments. Genomic DNA isolation. Genomic DNA was isolated following a modification of the method described by Sherman et al. (1986) . Mycelium was obtained by filtration of a culture of 10' spores incubated for 2 d at 30 mC in an orbital shaker in 200 ml minimal medium (Avalos et al., 1985) supplemented with 1 g yeast extract l − ". The mycelial pad was washed with water, dried with filter paper, covered with liquid nitrogen in a precooled mortar and quickly ground to a fine powder. The latter was mixed immediately with 7n5 ml Tris\EDTA (50 mM Tris, 20 mM EDTA, pH 7n5) and 0n5 ml SDS (100 g l − ") and heated at 65 mC for 30 min. It was then mixed with 2n3 ml 5 M potassium acetate, maintained at 4 mC for 30-60 min, and centrifuged at 9000 g for 10 min. The supernatant was filtered through a gauze, mixed with 2 vols ethanol, and incubated overnight at 4 mC before centrifugation at 9000 g for 10 min. The pellet was washed twice with ethanol (700 ml l − "), suspended in 3 ml Tris\EDTA, and treated with 15 µl bovine pancreas ribonuclease A (10 g l − ") for 30 min at 37 mC. The sample was mixed with 2 ml phenol\chloroform\isoamyl alcohol (25 : 24 : 1, by vol.) to stop digestion and centrifuged at 3500 g for 5 min. The water fraction was washed twice with chloroform\isoamyl alcohol (15 : 1, v\v), transferred to a new clean tube, mixed with 1 vol. 2-propanol, and centrifuged at 1000 g for 5 min. The precipitate was washed twice with ethanol (700 ml l − "), dried and resuspended in 0n5 ml Tris\ EDTA solution.
Southern hybridization and PCR replication. Genomic DNA (approx. 5 µg) was digested overnight with the indicated restriction enzymes. It was then separated by electrophoresis in an agarose gel (1 %), and transferred to a nylon membrane (Hybond ; Amersham). Hybridization was carried out with a 318 bp fragment of the G. fujikuroi gene for HMG-CoA reductase, obtained by in vitro PCR replication of genomic DNA using the primers described by Corrochano & Avalos (1992) , labelled with digoxigenin-11-dUTP. Detection was carried out with a chemiluminescent substrate (CSPD) following the manufacturer's recommendations (Boehringer Mannheim). Hybridization and washing were carried out at 65 mC. For other DNA manipulations and technical details see Sambrook et al. (1989) .
RESULTS

Effects of lovastatin and mevalonate
The wild-type and the SG22 mutant of G. fujikuroi resisted high concentrations of lovastatin in the culture medium. Growth was not inhibited in the presence of up to 5 µM lovastatin. Table 1 shows that lovastatin did not affect the production of essential terpenoids such as sterols, and dispensable ones such as carotenoids. In contrast, lovastatin inhibited the accumulation of gibberellins in the culture medium. The inhibition was dose-dependent ( Fig. 1a) and occurred whether the inhibitor was initially present in the medium or was added to cultures already engaged in gibberellin production (Fig. 1b) . The inhibition by lovastatin was counteracted by the addition of mevalonate. The gibberellin content of 10-d-old cultures initially supplemented with 5 µM lovastatin was 24p1n5 mg l −" , but reached 64p6n1 if supplemented with 10 mM - mevalonate at the age of 3 d. Control cultures without lovastatin or mevalonate contained 68p4n5 mg l −" .
Reduction of HMG-CoA by cell-free extracts
Radioactively labelled HMG-CoA was converted to mevalonate by cell-free extracts of G. fujikuroi. The highest activity was found in young cultures, 2 or 3 d old (Fig. 2a) , and declined with the cessation of balanced growth, the exhaustion of the nitrogen source, and the onset of gibberellin production (Candau et al., 1992) . The activity was very sensitive to lovastatin : addition of 10 nM lovastatin to the extracts lowered their activity to about one-half of the original activity, and addition of 100 nM rendered it practically undetectable (Fig. 2b) . Treatments either by sonication or with 0n05-1 % Triton X-100 of the cell-free extracts did not produce changes in the enzyme activity.
PCR and Southern blot analysis
The DNA molecule obtained by PCR with the two oligonucleotide mixtures treated with different restriction enzymes (Fig. 3a) was coincident with that expected from the sequence of the gene already known (Fig. 3b) . The same fragment (Fig. 3b) used as a probe to detect the DNA fragments separated by gel electrophoresis after complete digestion of the genome of this fungus with eight different restriction enzymes led to the detection of a single DNA band in each case (Fig. 4) . Repetition at lower annealing and washing temperatures did not reveal additional specific bands.
DISCUSSION
G. fujikuroi grows and produces carotenoids in the presence of high concentrations of lovastatin in the culture medium. This is not the case for other organisms ; thus, P. blakesleeanus does not grow in the presence of 1 µM lovastatin (Bejarano & Cerda! -Olmedo, 1992) . The inhibition of gibberellin biosynthesis in G. fujikuroi (Shiao, 1983 ; Lewer & McMillan, 1983 ) is a surprising observation in view of the lack of inhibition of the synthesis of all essential terpenoids and of carotenoids. Since sterols, carotenoids and gibberellins are synthesized in different subcellular compartments (Domenech et al., 1996) , the inhibition of gibberellin biosynthesis by lovastatin and the lack of effect on growth and pigmentation would be explained if the respective subcellular compartments are not equally accessible to lovastatin. In support of this point is the fact that the HMG-CoA reductase is very sensitive to lovastatin in vitro, but differentially sensitive to lovastatin in vivo. Therefore, the above results may be explained by postulating the physical separation of the terpenoid pathways.
The second point supporting the idea that the enzyme is not freely accessed by its inhibitor are the results obtained by Southern hybridization and PCR amplification. The results of both types of experiments led to conclusions very similar to those reported by Woitek et al. (1997) for different strains of G. fujikuroi. HMGCoA reductase appears to be the product of a single gene. The restriction pattern of the PCR product is especially informative : our mixture of primer oligonucleotides should have allowed detection of all known genes for HMG-CoA reductases (Corrochano & Avalos, 1992) , but amplification resulted in only one DNA sequence that appears to be unique. Although a single hybridizing band in a genomic Southern blot may constitute proof that a gene is present in one copy per haploid genome, our results do not rule out the fact that a tandemly repeated gene array would give the same pattern of hybridization.
An independent explanation would be that lovastatin inhibits not only HMG-CoA reductase, but also a step specific for gibberellin biosynthesis. This would require different compartmentation, with only the latter step accessible to lovastatin in vivo. The normal gibberellin biosynthesis in the presence of lovastatin and mevalonate suggests that gibberellins are produced freely from mevalonate in the presence of lovastatin. Mevalonate should have a regulatory effect of its own that leads to a total blockage of gibberellin production when present initially in the culture media (Domenech et al., 1996) ; for this reason mevalonate was added to 3-d-old cultures.
Alternatively, G. fujikuroi could possess two HMGCoA reductases. The essential terpenoids and the carotenoids would be made by an enzyme belonging to a wholly new sequence class, resistant to lovastatin, and undetectable in the in vitro assay. This hypothesis, however, lacks experimental support and is contrary to observations of enzymes from numerous organisms.
(CONICET), Consejo de Investigaciones Cientı! ficas y Tecnolo! gicas de la Provincia de Co! rdoba (CONICOR), the Spanish Government (DGES PB96-1336, Programa de Colaboracio! n con Iberoame! rica), Junta de Andalucı! a (Group CVI0119) and the European Union (FAIR CT96-1633).
C. E. D. is a Career Member of the CONICET and W. G. has a fellowship from the CONICET of the Repu! blica Argentina. We thank Drs D. Gonzalez-Pacanowska and A. Montalvetti for useful help in the assay of HMG-CoA reductase activity.
